FRACTA THERAPEUTICS AS

FRACTA THERAPEUTICS AS is registered as a limited company in Oslo, Oslo with organisation number 926960288. The business is classified under research and experimental development on natural sciences and engineering (NACE 72.100). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 12000 shares. The company's stated purpose is: “Å utvikle, produsere og selge produkter innenfor bioteknologi og tilgrensende områder. Formålet kan fremmes ved deltagelse i eller samarbeid med andre foretak i inn- og utland eller rådgivende virksomhet.”. The most recent filed accounts, for the 2024 financial year, show NOK 225,000 in revenue and NOK 5,000 in operating profit.

Key figures · 2024

Revenue

NOK 225,000

Operating profit

NOK 5,000

Equity

NOK 14,000

Est. value

NOK 33,000

Financial health · 2024

Liquidity

7.84

Very good

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

87.3%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns FRACTA THERAPEUTICS AS?

STAV-NORAAS HOLDING AS

33.3%

FRACTA THERAPEUTICS AS

NOK 225,000 rev. · NOK 5,000 profit

FRACTA THERAPEUTICS AS has 3 registered shareholders:

• STAV-NORAAS HOLDING AS 33.3%
• ØIEN EQUITIES AS 33.3%
• MJAALAND CAPITAL AS 33.3%

All shareholders and roles →

Frequently asked questions about FRACTA THERAPEUTICS AS

Who owns FRACTA THERAPEUTICS AS?

STAV-NORAAS HOLDING AS is the largest registered owner, with 33.3%.

What is the revenue of FRACTA THERAPEUTICS AS?

FRACTA THERAPEUTICS AS had revenue of NOK 225,000 in 2024.

Where is FRACTA THERAPEUTICS AS based?

FRACTA THERAPEUTICS AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.